¹⁸F Choline PET/CT in the Preoperative Staging of Prostate Cancer in Patients with Intermediate or High Risk of Extracapsular Disease: A Prospective Study of 130 Patients

References

• 1 Jemal A , Murray T , Ward E , et al. . Cancer statistics, 2005. CA Cancer J Clin 2005;55(1):10–30.
  Medline Google Scholar
• 2 Hricak H , Schöder H , Pucar D , et al. . Advances in imaging in the postoperative patient with a rising prostate-specific antigen level. Semin Oncol 2003;30(5):616–634.
  Medline Google Scholar
• 3 Abuzallouf S , Dayes I , Lukka H . Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol 2004;171(6 pt 1):2122–2127.
  Medline Google Scholar
• 4 Hricak H , Choyke PL , Eberhardt SC , Leibel SA , Scardino PT . Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007;243(1):28–53.
  Google Scholar
• 5 Effert PJ , Bares R , Handt S , Wolff JM , Büll U , Jakse G . Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. J Urol 1996;155(3):994–998.
  Medline Google Scholar
• 6 Heicappell R , Müller-Mattheis V , Reinhardt M , et al. . Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-[(18)F]-2-deoxy-D-glucose. Eur Urol 1999;36(6):582–587.
  Medline Google Scholar
• 7 Hofer C , Laubenbacher C , Block T , Breul J , Hartung R , Schwaiger M . Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Eur Urol 1999;36(1):31–35.
  Medline Google Scholar
• 8 Liu IJ , Zafar MB , Lai YH , Segall GM , Terris MK . Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer. Urology 2001;57(1):108–111.
  Medline Google Scholar
• 9 Morris MJ , Akhurst T , Osman I , et al. . Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer. Urology 2002;59(6):913–918.
  Medline Google Scholar
• 10 Shreve PD , Grossman HB , Gross MD , Wahl RL . Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology 1996;199(3):751–756.
  Google Scholar
• 11 Langsteger W , Heinisch M , Fogelman I . The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med 2006;36(1):73–92.
  Medline Google Scholar
• 12 Cimitan M , Bortolus R , Morassut S , et al. . [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 2006;33(12):1387–1398.
  Medline Google Scholar
• 13 Reske SN , Blumstein NM , Neumaier B , et al. . Imaging prostate cancer with 11C-choline PET/CT. J Nucl Med 2006;47(8):1249–1254.
  Medline Google Scholar
• 14 Kwee SA , Wei H , Sesterhenn I , Yun D , Coel MN . Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. J Nucl Med 2006;47(2):262–269.
  Medline Google Scholar
• 15 Schmid DT , John H , Zweifel R , et al. . Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology 2005;235(2):623–628.
  Google Scholar
• 16 Schiavina R , Scattoni V , Castellucci P , et al. . 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. Eur Urol 2008;54(2):392–401.
  Medline Google Scholar
• 17 Testa C , Schiavina R , Lodi R , et al. . Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. Radiology 2007;244(3):797–806.
  Google Scholar
• 18 Häcker A , Jeschke S , Leeb K , et al. . Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 2006;176(5):2014–2018 ; discussion 2018–2019.
  Medline Google Scholar
• 19 Scher B , Seitz M , Albinger W , et al. . Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer. Eur J Nucl Med Mol Imaging 2007;34(1):45–53.
  Medline Google Scholar
• 20 Goldstein NS , Bégin LR , Grody WW , Novak JM , Qian J , Bostwick DG . Minimal or no cancer in radical prostatectomy specimens: report of 13 cases of the “vanishing cancer phenomenon”. Am J Surg Pathol 1995;19(9):1002–1009.
  Medline Google Scholar
• 21 Vassiliev D , Krasikova R , Kutznetsova O , Federova O , Nader M . Simple HPLC method for the detection of N,N-dimethylaminoethanol in the preparation of [N-methyl-11C] choline. Eur J Nucl Med Mol Imaging 2003;30(suppl):342P.
  Google Scholar
• 22 Schröder FH , Roach M , Scardino P . Clinical decisions: management of prostate cancer. N Engl J Med 2008;359(24):2605–2609.
  Medline Google Scholar
• 23 Harisinghani MG , Barentsz J , Hahn PF , et al. . Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003;348(25):2491–2499.
  Medline Google Scholar
• 24 Breeuwsma AJ , Pruim J , Jongen MM , et al. . In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer. Eur J Nucl Med Mol Imaging 2005;32(6):668–673.
  Medline Google Scholar
• 25 Zheng QH , Gardner TA , Raikwar S , et al. . [11C]Choline as a PET biomarker for assessment of prostate cancer tumor models. Bioorg Med Chem 2004;12(11):2887–2893.
  Medline Google Scholar
• 26 de Jong IJ , Pruim J , Elsinga PH , Vaalburg W , Mensink HJ . Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. J Nucl Med 2003;44(3):331–335.
  Medline Google Scholar
• 27 Husarik DB , Miralbell R , Dubs M , et al. . Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging 2008;35(2):253–263.
  Medline Google Scholar
• 28 Conti M . State of the art and challenges of time-of-flight PET. Phys Med 2009;25(1):1–11.
  Medline Google Scholar
• 29 Hricak H , Dooms GC , Jeffrey RB , et al. . Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging. Radiology 1987;162(2):331–336.
  Google Scholar
• 30 Platt JF , Bree RL , Schwab RE . The accuracy of CT in the staging of carcinoma of the prostate. AJR Am J Roentgenol 1987;149(2):315–318.
  Medline Google Scholar
• 31 Golimbu M , Morales P , Al-Askari S , Shulman Y . CAT scanning in staging of prostatic cancer. Urology 1981;18(3):305–308.
  Medline Google Scholar
• 32 Rørvik J , Halvorsen OJ , Albrektsen G , Haukaas S . Lymphangiography combined with biopsy and computer tomography to detect lymph node metastases in localized prostate cancer. Scand J Urol Nephrol 1998;32(2):116–119.
  Medline Google Scholar
• 33 Wolf JS , Cher M , Dall’era M , Presti JC , Hricak H , Carroll PR . The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol 1995;153(3 pt 2):993–999.
  Medline Google Scholar
• 34 Beheshti M , Vali R , Waldenberger P , et al. . Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study. Eur J Nucl Med Mol Imaging 2008;35(10):1766–1774.
  Medline Google Scholar
• 35 Beheshti M , Vali R , Waldenberger P , et al. . The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT. Mol Imaging Biol, 2009;11(6):446–454.
  Medline Google Scholar
• 36 Beheshti M , Vali R , Langsteger W . [18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer. Eur J Nucl Med Mol Imaging 2007;34(8):1316–1317; author reply 1318–1319.
  Medline Google Scholar